Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:29915691

Establishment of a 12-gene expression signature to predict colon cancer prognosis.

Dalong Sun · Jing Chen · Longzi Liu · Guangxi Zhao · Pingping Dong · Bingrui Wu · Jun Wang · Ling Dong

PeerJ · 2018 doi:10.7717/peerj.4942

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:29915691
kind
science-record
content_hash
sha256:3aa96f4f61c4d241723383f388d12d666a9bda34b2e23cc8317887cb68c313ad
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:34Z
updated_at
2026-11-01T21:59:53Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Establishment of a 12-gene expression signature to predict colon cancer prognosis.
doi
10.7717/peerj.4942
pmid
29915691
authors array · 8 items
[0]
Dalong Sun
[1]
Jing Chen
[2]
Longzi Liu
[3]
Guangxi Zhao
[4]
Pingping Dong
[5]
Bingrui Wu
[6]
Jun Wang
[7]
Ling Dong
journal
PeerJ
year
2018
abstract
A robust and accurate gene expression signature is essential to assist oncologists to determine which subset of patients at similar Tumor-Lymph Node-Metastasis (TNM) stage has high recurrence risk and could benefit from adjuvant therapies. Here we applied a two-step supervised machine-learning method and established a 12-gene expression signature to precisely predict colon adenocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA). The predictive performance of the 12-gene signature was validated with two independent gene expression microarray datasets: GSE39582 includes 566 COAD cases for the development of six molecular subtypes with distinct clinical, molecular and survival characteristics; GSE17538 is a dataset containing 232 colon cancer patients for the generation of a metastasis gene expression profile to predict recurrence and death in COAD patients. The signature could effectively separate the poor prognosis patients from good prognosis group (disease specific survival (DSS): Kaplan Meier (KM) Log Rank p = 0.0034; overall survival (OS): KM Log Rank p = 0.0336) in GSE17538. For patients with proficient mismatch repair system (pMMR) in GSE39582, the signature could also effectively distinguish high risk group from low risk group (OS: KM Log Rank p = 0.005; Relapse free survival (RFS): KM Log Rank p = 0.022). Interestingly, advanced stage patients were significantly enriched in high 12-gene score group (Fisher's exact test p = 0.0003). After stage stratification, the signature could still distinguish poor prognosis patients in GSE17538 from good prognosis within stage II (Log Rank p = 0.01) and stage II & III (Log Rank p = 0.017) in the outcome of DFS. Within stage III or II/III pMMR patients treated with Adjuvant Chemotherapies (ACT) and patients with higher 12-gene score showed poorer prognosis (III, OS: KM Log Rank p = 0.046; III & II, OS: KM Log Rank p = 0.041). Among stage II/III pMMR patients with lower 12-gene scores in GSE39582, the subgroup receiving ACT showed significantly longer OS time compared with those who received no ACT (Log Rank p = 0.021), while there is no obvious difference between counterparts among patients with higher 12-gene scores (Log Rank p = 0.12). Besides COAD, our 12-gene signature is multifunctional in several other cancer types including kidney cancer, lung cancer, uveal and skin melanoma, brain cancer, and pancreatic cancer. Functional classification showed that seven of the twelve genes are involved in immune system function and regulation, so our 12-gene signature could potentially be used to guide decisions about adjuvant therapy for patients with stage II/III and pMMR COAD.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29915691
locator
sections[12] "Validation stage" paragraph 2
quote
Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The following information was supplied regarding data availability: Detailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively. The detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:29915691
locator
sections[32] "Data Availability Statement" paragraphs 1-4
quote
The following information was supplied regarding data availability: Detailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively. The detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The paper used a two-step supervised machine-learning method trained with TCGA COAD RNA-seq data and validated in independent GEO microarray cohorts; the resulting 12-gene signature separated prognosis groups, including in GSE17538 (DSS: KM Log Rank p = 0.0034; OS: KM Log Rank p = 0.0336) and in GSE39582 pMMR patients (OS: KM Log Rank p = 0.005; RFS: KM Log Rank p = 0.022).
kind
qualitative
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:29915691
locator
sections[0] "Abstract" paragraph 1
quote
Here we applied a two-step supervised machine-learning method and established a 12-gene expression signature to precisely predict colon adenocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA).
[1] object · 3 fields
asset
source:pmid:29915691
locator
sections[0] "Abstract" paragraph 1
quote
The signature could effectively separate the poor prognosis patients from good prognosis group (disease specific survival (DSS): Kaplan Meier (KM) Log Rank p = 0.0034; overall survival (OS): KM Log Rank p = 0.0336) in GSE17538.
[2] object · 3 fields
asset
source:pmid:29915691
locator
sections[0] "Abstract" paragraph 1
quote
For patients with proficient mismatch repair system (pMMR) in GSE39582, the signature could also effectively distinguish high risk group from low risk group (OS: KM Log Rank p = 0.005; Relapse free survival (RFS): KM Log Rank p = 0.022).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The paper used a two-step supervised machine-learning method trained with TCGA COAD RNA-seq data and validated in independent GEO microarray cohorts; the resulting 12-gene signature separated prognosis groups, including in GSE17538 (DSS: KM Log Rank p = 0.0034; OS: KM Log Rank p = 0.0336) and in GSE39582 pMMR patients (OS: KM Log Rank p = 0.005; RFS: KM Log Rank p = 0.022).
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:29915691
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE39582
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE39582
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:29915691
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.7717/peerj.4942
sha256
sha256:0a059dd79d8880e5dc8b0b6aac15d70cbe238f9075a788ea0ce2fed18149b825
bytes
53902
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.7717/peerj.4942
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC6004299
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE39582
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39582
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE39582
version
null
note
The following information was supplied regarding data availability: Detailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively. The detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The following information was supplied regarding data availability: Detailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively. The detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.
access_statement_kind
data_availability_statement
sample_accessions array · 585 items
[0]
GSM1681353
[1]
GSM1681354
[2]
GSM1681355
[3]
GSM1681356
[4]
GSM1681357
[5]
GSM1681358
[6]
GSM1681359
[7]
GSM1681360
[8]
GSM1681361
[9]
GSM1681362
[10]
GSM1681363
[11]
GSM1681364
[12]
GSM1681365
[13]
GSM1681366
[14]
GSM1681367
[15]
GSM1681368
[16]
GSM1681369
[17]
GSM1681370
[18]
GSM1681371
[19]
GSM971957
[20]
GSM971958
[21]
GSM971959
[22]
GSM971960
[23]
GSM971961
[24]
GSM971962
[25]
GSM971963
[26]
GSM971964
[27]
GSM971965
[28]
GSM971966
[29]
GSM971967
[30]
GSM971968
[31]
GSM971969
[32]
GSM971970
[33]
GSM971971
[34]
GSM971972
[35]
GSM971973
[36]
GSM971974
[37]
GSM971975
[38]
GSM971976
[39]
GSM971977
[40]
GSM971978
[41]
GSM971979
[42]
GSM971980
[43]
GSM971981
[44]
GSM971982
[45]
GSM971983
[46]
GSM971984
[47]
GSM971985
[48]
GSM971986
[49]
GSM971987
[50]
GSM971988
[51]
GSM971989
[52]
GSM971990
[53]
GSM971991
[54]
GSM971992
[55]
GSM971993
[56]
GSM971994
[57]
GSM971995
[58]
GSM971996
[59]
GSM971997
[60]
GSM971998
[61]
GSM971999
[62]
GSM972000
[63]
GSM972001
[64]
GSM972002
[65]
GSM972003
[66]
GSM972004
[67]
GSM972005
[68]
GSM972006
[69]
GSM972007
[70]
GSM972008
[71]
GSM972009
[72]
GSM972010
[73]
GSM972011
[74]
GSM972012
[75]
GSM972013
[76]
GSM972014
[77]
GSM972015
[78]
GSM972016
[79]
GSM972017
[80]
GSM972018
[81]
GSM972019
[82]
GSM972020
[83]
GSM972021
[84]
GSM972022
[85]
GSM972023
[86]
GSM972024
[87]
GSM972025
[88]
GSM972026
[89]
GSM972027
[90]
GSM972028
[91]
GSM972029
[92]
GSM972030
[93]
GSM972031
[94]
GSM972032
[95]
GSM972033
[96]
GSM972034
[97]
GSM972035
[98]
GSM972036
[99]
GSM972037
[100]
GSM972038
[101]
GSM972039
[102]
GSM972040
[103]
GSM972041
[104]
GSM972042
[105]
GSM972043
[106]
GSM972044
[107]
GSM972045
[108]
GSM972046
[109]
GSM972047
[110]
GSM972048
[111]
GSM972049
[112]
GSM972050
[113]
GSM972051
[114]
GSM972052
[115]
GSM972053
[116]
GSM972054
[117]
GSM972055
[118]
GSM972056
[119]
GSM972057
[120]
GSM972058
[121]
GSM972059
[122]
GSM972060
[123]
GSM972061
[124]
GSM972062
[125]
GSM972063
[126]
GSM972064
[127]
GSM972065
[128]
GSM972066
[129]
GSM972067
[130]
GSM972068
[131]
GSM972069
[132]
GSM972070
[133]
GSM972071
[134]
GSM972072
[135]
GSM972073
[136]
GSM972074
[137]
GSM972075
[138]
GSM972076
[139]
GSM972077
[140]
GSM972078
[141]
GSM972079
[142]
GSM972080
[143]
GSM972081
[144]
GSM972082
[145]
GSM972083
[146]
GSM972084
[147]
GSM972085
[148]
GSM972086
[149]
GSM972087
[150]
GSM972088
[151]
GSM972089
[152]
GSM972090
[153]
GSM972091
[154]
GSM972092
[155]
GSM972093
[156]
GSM972094
[157]
GSM972095
[158]
GSM972096
[159]
GSM972097
[160]
GSM972098
[161]
GSM972099
[162]
GSM972100
[163]
GSM972101
[164]
GSM972102
[165]
GSM972103
[166]
GSM972104
[167]
GSM972105
[168]
GSM972106
[169]
GSM972107
[170]
GSM972108
[171]
GSM972109
[172]
GSM972110
[173]
GSM972111
[174]
GSM972112
[175]
GSM972113
[176]
GSM972114
[177]
GSM972115
[178]
GSM972116
[179]
GSM972117
[180]
GSM972118
[181]
GSM972119
[182]
GSM972120
[183]
GSM972121
[184]
GSM972122
[185]
GSM972123
[186]
GSM972124
[187]
GSM972125
[188]
GSM972126
[189]
GSM972127
[190]
GSM972128
[191]
GSM972129
[192]
GSM972130
[193]
GSM972131
[194]
GSM972132
[195]
GSM972133
[196]
GSM972134
[197]
GSM972135
[198]
GSM972136
[199]
GSM972137
[200]
GSM972138
[201]
GSM972139
[202]
GSM972140
[203]
GSM972141
[204]
GSM972142
[205]
GSM972143
[206]
GSM972144
[207]
GSM972145
[208]
GSM972146
[209]
GSM972147
[210]
GSM972148
[211]
GSM972149
[212]
GSM972150
[213]
GSM972151
[214]
GSM972152
[215]
GSM972153
[216]
GSM972154
[217]
GSM972155
[218]
GSM972156
[219]
GSM972157
[220]
GSM972158
[221]
GSM972159
[222]
GSM972160
[223]
GSM972161
[224]
GSM972162
[225]
GSM972163
[226]
GSM972164
[227]
GSM972165
[228]
GSM972166
[229]
GSM972167
[230]
GSM972168
[231]
GSM972169
[232]
GSM972170
[233]
GSM972171
[234]
GSM972172
[235]
GSM972173
[236]
GSM972174
[237]
GSM972175
[238]
GSM972176
[239]
GSM972177
[240]
GSM972178
[241]
GSM972179
[242]
GSM972180
[243]
GSM972181
[244]
GSM972182
[245]
GSM972183
[246]
GSM972184
[247]
GSM972185
[248]
GSM972186
[249]
GSM972187
[250]
GSM972188
[251]
GSM972189
[252]
GSM972190
[253]
GSM972191
[254]
GSM972192
[255]
GSM972193
[256]
GSM972194
[257]
GSM972195
[258]
GSM972196
[259]
GSM972197
[260]
GSM972198
[261]
GSM972199
[262]
GSM972200
[263]
GSM972201
[264]
GSM972202
[265]
GSM972203
[266]
GSM972204
[267]
GSM972205
[268]
GSM972206
[269]
GSM972207
[270]
GSM972208
[271]
GSM972209
[272]
GSM972210
[273]
GSM972211
[274]
GSM972212
[275]
GSM972213
[276]
GSM972214
[277]
GSM972215
[278]
GSM972216
[279]
GSM972217
[280]
GSM972218
[281]
GSM972219
[282]
GSM972220
[283]
GSM972221
[284]
GSM972222
[285]
GSM972223
[286]
GSM972224
[287]
GSM972225
[288]
GSM972226
[289]
GSM972227
[290]
GSM972228
[291]
GSM972229
[292]
GSM972230
[293]
GSM972231
[294]
GSM972232
[295]
GSM972233
[296]
GSM972234
[297]
GSM972235
[298]
GSM972236
[299]
GSM972237
[300]
GSM972238
[301]
GSM972239
[302]
GSM972240
[303]
GSM972241
[304]
GSM972242
[305]
GSM972243
[306]
GSM972244
[307]
GSM972245
[308]
GSM972246
[309]
GSM972247
[310]
GSM972248
[311]
GSM972249
[312]
GSM972250
[313]
GSM972251
[314]
GSM972252
[315]
GSM972253
[316]
GSM972254
[317]
GSM972255
[318]
GSM972256
[319]
GSM972257
[320]
GSM972258
[321]
GSM972259
[322]
GSM972260
[323]
GSM972261
[324]
GSM972262
[325]
GSM972263
[326]
GSM972264
[327]
GSM972265
[328]
GSM972266
[329]
GSM972267
[330]
GSM972268
[331]
GSM972269
[332]
GSM972270
[333]
GSM972271
[334]
GSM972272
[335]
GSM972273
[336]
GSM972274
[337]
GSM972275
[338]
GSM972276
[339]
GSM972277
[340]
GSM972278
[341]
GSM972279
[342]
GSM972280
[343]
GSM972281
[344]
GSM972282
[345]
GSM972283
[346]
GSM972284
[347]
GSM972285
[348]
GSM972286
[349]
GSM972287
[350]
GSM972288
[351]
GSM972289
[352]
GSM972290
[353]
GSM972291
[354]
GSM972292
[355]
GSM972293
[356]
GSM972294
[357]
GSM972295
[358]
GSM972296
[359]
GSM972297
[360]
GSM972298
[361]
GSM972299
[362]
GSM972300
[363]
GSM972301
[364]
GSM972302
[365]
GSM972303
[366]
GSM972304
[367]
GSM972305
[368]
GSM972306
[369]
GSM972307
[370]
GSM972308
[371]
GSM972309
[372]
GSM972310
[373]
GSM972311
[374]
GSM972312
[375]
GSM972313
[376]
GSM972314
[377]
GSM972315
[378]
GSM972316
[379]
GSM972317
[380]
GSM972318
[381]
GSM972319
[382]
GSM972320
[383]
GSM972321
[384]
GSM972322
[385]
GSM972323
[386]
GSM972324
[387]
GSM972325
[388]
GSM972326
[389]
GSM972327
[390]
GSM972328
[391]
GSM972329
[392]
GSM972330
[393]
GSM972331
[394]
GSM972332
[395]
GSM972333
[396]
GSM972334
[397]
GSM972335
[398]
GSM972336
[399]
GSM972337
[400]
GSM972338
[401]
GSM972339
[402]
GSM972340
[403]
GSM972341
[404]
GSM972342
[405]
GSM972343
[406]
GSM972344
[407]
GSM972345
[408]
GSM972346
[409]
GSM972347
[410]
GSM972348
[411]
GSM972349
[412]
GSM972350
[413]
GSM972351
[414]
GSM972352
[415]
GSM972353
[416]
GSM972354
[417]
GSM972355
[418]
GSM972356
[419]
GSM972357
[420]
GSM972358
[421]
GSM972359
[422]
GSM972360
[423]
GSM972361
[424]
GSM972362
[425]
GSM972363
[426]
GSM972364
[427]
GSM972365
[428]
GSM972366
[429]
GSM972367
[430]
GSM972368
[431]
GSM972369
[432]
GSM972370
[433]
GSM972371
[434]
GSM972372
[435]
GSM972373
[436]
GSM972374
[437]
GSM972375
[438]
GSM972376
[439]
GSM972377
[440]
GSM972378
[441]
GSM972379
[442]
GSM972380
[443]
GSM972381
[444]
GSM972382
[445]
GSM972383
[446]
GSM972384
[447]
GSM972385
[448]
GSM972386
[449]
GSM972387
[450]
GSM972388
[451]
GSM972389
[452]
GSM972390
[453]
GSM972391
[454]
GSM972392
[455]
GSM972393
[456]
GSM972394
[457]
GSM972395
[458]
GSM972396
[459]
GSM972397
[460]
GSM972398
[461]
GSM972399
[462]
GSM972400
[463]
GSM972401
[464]
GSM972402
[465]
GSM972403
[466]
GSM972404
[467]
GSM972405
[468]
GSM972406
[469]
GSM972407
[470]
GSM972408
[471]
GSM972409
[472]
GSM972410
[473]
GSM972411
[474]
GSM972412
[475]
GSM972413
[476]
GSM972414
[477]
GSM972415
[478]
GSM972416
[479]
GSM972417
[480]
GSM972418
[481]
GSM972419
[482]
GSM972420
[483]
GSM972421
[484]
GSM972422
[485]
GSM972423
[486]
GSM972424
[487]
GSM972425
[488]
GSM972426
[489]
GSM972427
[490]
GSM972428
[491]
GSM972429
[492]
GSM972430
[493]
GSM972431
[494]
GSM972432
[495]
GSM972433
[496]
GSM972434
[497]
GSM972435
[498]
GSM972436
[499]
GSM972437
[500]
GSM972438
[501]
GSM972439
[502]
GSM972440
[503]
GSM972441
[504]
GSM972442
[505]
GSM972443
[506]
GSM972444
[507]
GSM972445
[508]
GSM972446
[509]
GSM972447
[510]
GSM972448
[511]
GSM972449
[512]
GSM972450
[513]
GSM972451
[514]
GSM972452
[515]
GSM972453
[516]
GSM972454
[517]
GSM972455
[518]
GSM972456
[519]
GSM972457
[520]
GSM972458
[521]
GSM972459
[522]
GSM972460
[523]
GSM972461
[524]
GSM972462
[525]
GSM972463
[526]
GSM972464
[527]
GSM972465
[528]
GSM972466
[529]
GSM972467
[530]
GSM972468
[531]
GSM972469
[532]
GSM972470
[533]
GSM972471
[534]
GSM972472
[535]
GSM972473
[536]
GSM972474
[537]
GSM972475
[538]
GSM972476
[539]
GSM972477
[540]
GSM972478
[541]
GSM972479
[542]
GSM972480
[543]
GSM972481
[544]
GSM972482
[545]
GSM972483
[546]
GSM972484
[547]
GSM972485
[548]
GSM972486
[549]
GSM972487
[550]
GSM972488
[551]
GSM972489
[552]
GSM972490
[553]
GSM972491
[554]
GSM972492
[555]
GSM972493
[556]
GSM972494
[557]
GSM972495
[558]
GSM972496
[559]
GSM972497
[560]
GSM972498
[561]
GSM972499
[562]
GSM972500
[563]
GSM972501
[564]
GSM972502
[565]
GSM972503
[566]
GSM972504
[567]
GSM972505
[568]
GSM972506
[569]
GSM972507
[570]
GSM972508
[571]
GSM972509
[572]
GSM972510
[573]
GSM972511
[574]
GSM972512
[575]
GSM972513
[576]
GSM972514
[577]
GSM972515
[578]
GSM972516
[579]
GSM972517
[580]
GSM972518
[581]
GSM972519
[582]
GSM972520
[583]
GSM972521
[584]
GSM972522
sample_count
585
group_sizes
null
group_sizes_basis
null
platform
570
taxon
Homo sapiens
title
Gene expression Classification of Colon Cancer defines six molecular subtypes with distinct clinical, molecular and survival characteristics [Expression]
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:29915691:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:e063dffe84c46123eaf3ce08fd75a018dbdb53c5f8ff2ec20c42561a21d819ce
bytes
1051
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#table-1
version
null
note
Clinicopathologic features of 240 TCGA COAD patients.
structure object · 5 fields
pmcid
PMC6004299
section_index
11
section_title
Phase II
row_count
21
column_count
4
table object · 8 fields
label
Table 1
caption
Clinicopathologic features of 240 TCGA COAD patients.
rows array · 21 items
[0] array · 4 items
[0]
Characteristic
[1]
Training set (N = 119)
[2]
Testing set (N = 121)
[3]
pvalue
[1] array · 4 items
[0]
[1]
No. of patients (%)
[2]
No. of patients (%)
[3]
[2] array · 4 items
[0]
Age (mean ± SD)
[1]
66.4 ± 13.0
[2]
63.2 ± 13.8
[3]
0.069a
[3] array · 4 items
[0]
Gender
[1]
[2]
[3]
[4] array · 4 items
[0]
Male
[1]
60 (50.4%)
[2]
54 (44.6%)
[3]
0.438b
[5] array · 3 items
[0]
Female
[1]
59 (49.6%)
[2]
67 (55.4%)
[6] array · 4 items
[0]
Stage
[1]
[2]
[3]
[7] array · 4 items
[0]
I
[1]
20 (16.8%)
[2]
20 (16.5%)
[3]
0.998c
[8] array · 3 items
[0]
II
[1]
47 (39.5%)
[2]
48 (39.7%)
[9] array · 3 items
[0]
III and IV
[1]
52 (43.7%)
[2]
53 (43.8%)
[10] array · 4 items
[0]
Primary tumor
[1]
[2]
[3]
[11] array · 4 items
[0]
T1 and T2
[1]
20 (16.8%)
[2]
23 (19.0%)
[3]
0.737b
[12] array · 3 items
[0]
T3 and T4
[1]
99 (83.2%)
[2]
98 (81.0%)
[13] array · 4 items
[0]
Microsatellite status
[1]
[2]
[3]
[14] array · 4 items
[0]
MSI-L
[1]
23 (19.3%)
[2]
23 (19.0%)
[3]
0.995c
[15] array · 3 items
[0]
MSI-H
[1]
20 (16.8%)
[2]
20 (16.5%)
[16] array · 3 items
[0]
MSS
[1]
76 (63.9%)
[2]
78 (64.4%)
[17] array · 4 items
[0]
Lymphatic_invasion
[1]
[2]
[3]
[18] array · 4 items
[0]
No
[1]
77 (64.7%)
[2]
77 (63.6%)
[3]
0.999b
[19] array · 3 items
[0]
Yes
[1]
33 (27.7%)
[2]
34 (28.1%)
[20] array · 4 items
[0]
Unknown
[1]
9 (7.6%)
[2]
10 (8.3%)
[3]
Excluded
locator
section[11]/table-wrap[1]#table-1
[3] object · 16 fields
id
asset:table:pmid:29915691:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:dd8832744bcb96f33758e1b250d1d2622700ddebd99de81684746c3a6155ad50
bytes
1716
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[14]/table-wrap[1]#table-2
version
null
note
Statistics of the ROC analysis.
structure object · 5 fields
pmcid
PMC6004299
section_index
14
section_title
Development of signature prototype
row_count
27
column_count
6
table object · 8 fields
label
Table 2
caption
Statistics of the ROC analysis.
rows array · 27 items
[0] array · 5 items
[0]
Signature
[1]
AUC
[2]
SE
[3]
Progressivep
[4]
Progressive 95% CIs
[1] array · 6 items
[0]
[1]
[2]
[3]
[4]
Lower bound
[5]
Upper bound
[2] array · 6 items
[0]
16-gene
[1]
0.7517
[2]
0.0531
[3]
0.0000
[4]
0.6476
[5]
0.8558
[3] array · 6 items
[0]
36-gene
[1]
0.7600
[2]
0.0529
[3]
0.0000
[4]
0.6562
[5]
0.8637
[4] array · 6 items
[0]
40-gene
[1]
0.7653
[2]
0.0520
[3]
0.0000
[4]
0.6634
[5]
0.8672
[5] array · 6 items
[0]
42-gene
[1]
0.7609
[2]
0.0525
[3]
0.0000
[4]
0.6581
[5]
0.8638
[6] array · 6 items
[0]
44-gene
[1]
0.7604
[2]
0.0525
[3]
0.0000
[4]
0.6576
[5]
0.8633
[7] array · 6 items
[0]
46-gene
[1]
0.7614
[2]
0.0524
[3]
0.0000
[4]
0.6588
[5]
0.8641
[8] array · 6 items
[0]
48-gene
[1]
0.7575
[2]
0.0528
[3]
0.0000
[4]
0.6540
[5]
0.8610
[9] array · 6 items
[0]
50-gene
[1]
0.7541
[2]
0.0530
[3]
0.0000
[4]
0.6503
[5]
0.8580
[10] array · 6 items
[0]
56-gene
[1]
0.7493
[2]
0.0532
[3]
0.0000
[4]
0.6450
[5]
0.8536
[11] array · 6 items
[0]
58-gene
[1]
0.7488
[2]
0.0533
[3]
0.0000
[4]
0.6444
[5]
0.8532
[12] array · 6 items
[0]
60-gene
[1]
0.7483
[2]
0.0532
[3]
0.0000
[4]
0.6439
[5]
0.8527
[13] array · 6 items
[0]
62-gene
[1]
0.7478
[2]
0.0533
[3]
0.0000
[4]
0.6433
[5]
0.8524
[14] array · 6 items
[0]
64-gene
[1]
0.7468
[2]
0.0534
[3]
0.0001
[4]
0.6421
[5]
0.8515
[15] array · 6 items
[0]
66-gene
[1]
0.7459
[2]
0.0535
[3]
0.0001
[4]
0.6409
[5]
0.8508
[16] array · 6 items
[0]
68-gene
[1]
0.7449
[2]
0.0534
[3]
0.0001
[4]
0.6402
[5]
0.8496
[17] array · 6 items
[0]
70-gene
[1]
0.7459
[2]
0.0534
[3]
0.0001
[4]
0.6412
[5]
0.8505
[18] array · 6 items
[0]
72-gene
[1]
0.7468
[2]
0.0534
[3]
0.0001
[4]
0.6422
[5]
0.8514
[19] array · 6 items
[0]
74-gene
[1]
0.7444
[2]
0.0535
[3]
0.0001
[4]
0.6395
[5]
0.8493
[20] array · 6 items
[0]
76-gene
[1]
0.7444
[2]
0.0535
[3]
0.0001
[4]
0.6396
[5]
0.8492
[21] array · 6 items
[0]
78-gene
[1]
0.7430
[2]
0.0537
[3]
0.0001
[4]
0.6377
[5]
0.8482
[22] array · 6 items
[0]
80-gene
[1]
0.7410
[2]
0.0539
[3]
0.0001
[4]
0.6354
[5]
0.8467
[23] array · 6 items
[0]
82-gene
[1]
0.7420
[2]
0.0538
[3]
0.0001
[4]
0.6365
[5]
0.8474
[24] array · 6 items
[0]
84-gene
[1]
0.7410
[2]
0.0539
[3]
0.0001
[4]
0.6353
[5]
0.8467
[25] array · 6 items
[0]
86-gene
[1]
0.7410
[2]
0.0539
[3]
0.0001
[4]
0.6354
[5]
0.8466
[26] array · 6 items
[0]
118-gene
[1]
0.7347
[2]
0.0542
[3]
0.0001
[4]
0.6284
[5]
0.8410
locator
section[14]/table-wrap[1]#table-2
[4] object · 16 fields
id
asset:table:pmid:29915691:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:9920b5557cb701909e226ace8b5026d5422f57127251d9fadf79c2f5e91d5869
bytes
550
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[1]#table-3
version
null
note
Distribution of advanced stage patients between high- and low-score group.Fisher’s exact test was used for statistical analysis.
structure object · 5 fields
pmcid
PMC6004299
section_index
16
section_title
Prognostic values of the 12-gene signature in other COAD datasets
row_count
5
column_count
5
table object · 8 fields
label
Table 3
caption
Distribution of advanced stage patients between high- and low-score group.Fisher’s exact test was used for statistical analysis.
rows array · 5 items
[0] array · 5 items
[0]
Dataset
[1]
Group
[2]
Stage I & II
[3]
Stage III & IV
[4]
pvalue
[1] array · 5 items
[0]
GSE17538
[1]
High score group
[2]
19 (20%)
[3]
78 (80%)
[4]
0.0003
[2] array · 3 items
[0]
Low score group
[1]
43 (44%)
[2]
54 (56%)
[3] array · 5 items
[0]
TCGA
[1]
High score group
[2]
53 (49%)
[3]
55 (51%)
[4]
0.0277
[4] array · 3 items
[0]
Low score group
[1]
69 (64%)
[2]
38 (36%)
locator
section[16]/table-wrap[1]#table-3
gaps array · 2 items
[0]
asset:data:geo:GSE39582 not downloaded
[1]
asset:data:geo:GSE39582 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
KM
[2] object · 10 fields
id
method-3
family
contingency_analysis
specific
fisher_exact
label
Categorical (contingency table) analysis
dsl_operations array · 2 items
[0]
contingency_table
[1]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.7
band
medium
quote
Fisher's exact
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: log_rank_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE39582
[1]
GSE17538 (GSE17536 and GSE17537)
resolved_accessions array · 1 item
[0]
GSE39582
statements array · 1 item
[0]
The following information was supplied regarding data availability: Detailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively. The detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.
basis
The paper names GSE39582 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
logrank_test
assets array · 5 items
[0]
source:pmid:29915691
[1]
data:geo:GSE39582
[2]
asset:table:pmid:29915691:1
[3]
asset:table:pmid:29915691:2
[4]
asset:table:pmid:29915691:3
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE39582
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:34:57Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
117338
completion_tokens
4584
cached_tokens
2104
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:29915691
type
paper
label
pmid:29915691
[1] object · 3 fields
id
source:pmid:29915691
type
manuscript
label
PMID 29915691 full text
[2] object · 3 fields
id
data:geo:GSE39582
type
dataset
label
GEO GSE39582
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:29915691
type
paper
label
pmid:29915691
[1] object · 3 fields
id
source:pmid:29915691
type
manuscript
label
PMID 29915691 full text
[2] object · 3 fields
id
data:geo:GSE39582
type
dataset
label
GEO GSE39582
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-29915691
type
extraction
used array · 1 item
[0]
source:pmid:29915691
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE39582
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE39582
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:29915691
parent_hash
sha256:83401a0c7bbfbb5cc1403c78f07d24ad1b1e17385a10ff26cffaaeae4e53ca51
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:GSE39582 licence not read
[1]
asset:data:geo:GSE39582 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
denocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome At
[1]
inoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA). Th
order_basis
paper_text_order:460
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
lidated with two independent gene expression microarray datasets: GSE39582 includes 566 COAD cases f
order_basis
paper_text_order:627
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
logrank_test
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different.
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:29915691", "kind": "science-record", "revision": 7, "content_hash": "sha256:3aa96f4f61c4d241723383f388d12d666a9bda34b2e23cc8317887cb68c313ad", "created_at": "2026-11-01T15:40:34Z", "updated_at": "2026-11-01T21:59:53Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Establishment of a 12-gene expression signature to predict colon cancer prognosis.", "doi": "10.7717/peerj.4942", "pmid": "29915691", "authors": ["Dalong Sun", "Jing Chen", "Longzi Liu", "Guangxi Zhao", "Pingping Dong", "Bingrui Wu", "Jun Wang", "Ling Dong"], "journal": "PeerJ", "year": 2018, "abstract": "A robust and accurate gene expression signature is essential to assist oncologists to determine which subset of patients at similar Tumor-Lymph Node-Metastasis (TNM) stage has high recurrence risk and could benefit from adjuvant therapies. Here we applied a two-step supervised machine-learning method and established a 12-gene expression signature to precisely predict colon adenocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA). The predictive performance of the 12-gene signature was validated with two independent gene expression microarray datasets: GSE39582 includes 566 COAD cases for the development of six molecular subtypes with distinct clinical, molecular and survival characteristics; GSE17538 is a dataset containing 232 colon cancer patients for the generation of a metastasis gene expression profile to predict recurrence and death in COAD patients. The signature could effectively separate the poor prognosis patients from good prognosis group (disease specific survival (DSS): Kaplan Meier (KM) Log Rank p = 0.0034; overall survival (OS): KM Log Rank p = 0.0336) in GSE17538. For patients with proficient mismatch repair system (pMMR) in GSE39582, the signature could also effectively distinguish high risk group from low risk group (OS: KM Log Rank p = 0.005; Relapse free survival (RFS): KM Log Rank p = 0.022). Interestingly, advanced stage patients were significantly enriched in high 12-gene score group (Fisher's exact test p = 0.0003). After stage stratification, the signature could still distinguish poor prognosis patients in GSE17538 from good prognosis within stage II (Log Rank p = 0.01) and stage II & III (Log Rank p = 0.017) in the outcome of DFS. Within stage III or II/III pMMR patients treated with Adjuvant Chemotherapies (ACT) and patients with higher 12-gene score showed poorer prognosis (III, OS: KM Log Rank p = 0.046; III & II, OS: KM Log Rank p = 0.041). Among stage II/III pMMR patients with lower 12-gene scores in GSE39582, the subgroup receiving ACT showed significantly longer OS time compared with those who received no ACT (Log Rank p = 0.021), while there is no obvious difference between counterparts among patients with higher 12-gene scores (Log Rank p = 0.12). Besides COAD, our 12-gene signature is multifunctional in several other cancer types including kidney cancer, lung cancer, uveal and skin melanoma, brain cancer, and pancreatic cancer. Functional classification showed that seven of the twelve genes are involved in immune system function and regulation, so our 12-gene signature could potentially be used to guide decisions about adjuvant therapy for patients with stage II/III and pMMR COAD.", "claims": [{"id": "claim-method", "statement": "Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29915691", "locator": "sections[12] \"Validation stage\" paragraph 2", "quote": "Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The following information was supplied regarding data availability:\nDetailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively.\nThe detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29915691", "locator": "sections[32] \"Data Availability Statement\" paragraphs 1-4", "quote": "The following information was supplied regarding data availability:\nDetailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively.\nThe detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The paper used a two-step supervised machine-learning method trained with TCGA COAD RNA-seq data and validated in independent GEO microarray cohorts; the resulting 12-gene signature separated prognosis groups, including in GSE17538 (DSS: KM Log Rank p = 0.0034; OS: KM Log Rank p = 0.0336) and in GSE39582 pMMR patients (OS: KM Log Rank p = 0.005; RFS: KM Log Rank p = 0.022).", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:29915691", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Here we applied a two-step supervised machine-learning method and established a 12-gene expression signature to precisely predict colon adenocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA)."}, {"asset": "source:pmid:29915691", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "The signature could effectively separate the poor prognosis patients from good prognosis group (disease specific survival (DSS): Kaplan Meier (KM) Log Rank p = 0.0034; overall survival (OS): KM Log Rank p = 0.0336) in GSE17538."}, {"asset": "source:pmid:29915691", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "For patients with proficient mismatch repair system (pMMR) in GSE39582, the signature could also effectively distinguish high risk group from low risk group (OS: KM Log Rank p = 0.005; Relapse free survival (RFS): KM Log Rank p = 0.022)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The paper used a two-step supervised machine-learning method trained with TCGA COAD RNA-seq data and validated in independent GEO microarray cohorts; the resulting 12-gene signature separated prognosis groups, including in GSE17538 (DSS: KM Log Rank p = 0.0034; OS: KM Log Rank p = 0.0336) and in GSE39582 pMMR patients (OS: KM Log Rank p = 0.005; RFS: KM Log Rank p = 0.022).", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:29915691"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE39582"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE39582"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:29915691", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.7717/peerj.4942", "sha256": "sha256:0a059dd79d8880e5dc8b0b6aac15d70cbe238f9075a788ea0ce2fed18149b825", "bytes": 53902, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.7717/peerj.4942", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC6004299", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE39582", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39582", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE39582", "version": null, "note": "The following information was supplied regarding data availability:\nDetailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively.\nThe detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The following information was supplied regarding data availability:\nDetailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively.\nThe detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1681353", "GSM1681354", "GSM1681355", "GSM1681356", "GSM1681357", "GSM1681358", "GSM1681359", "GSM1681360", "GSM1681361", "GSM1681362", "GSM1681363", "GSM1681364", "GSM1681365", "GSM1681366", "GSM1681367", "GSM1681368", "GSM1681369", "GSM1681370", "GSM1681371", "GSM971957", "GSM971958", "GSM971959", "GSM971960", "GSM971961", "GSM971962", "GSM971963", "GSM971964", "GSM971965", "GSM971966", "GSM971967", "GSM971968", "GSM971969", "GSM971970", "GSM971971", "GSM971972", "GSM971973", "GSM971974", "GSM971975", "GSM971976", "GSM971977", "GSM971978", "GSM971979", "GSM971980", "GSM971981", "GSM971982", "GSM971983", "GSM971984", "GSM971985", "GSM971986", "GSM971987", "GSM971988", "GSM971989", "GSM971990", "GSM971991", "GSM971992", "GSM971993", "GSM971994", "GSM971995", "GSM971996", "GSM971997", "GSM971998", "GSM971999", "GSM972000", "GSM972001", "GSM972002", "GSM972003", "GSM972004", "GSM972005", "GSM972006", "GSM972007", "GSM972008", "GSM972009", "GSM972010", "GSM972011", "GSM972012", "GSM972013", "GSM972014", "GSM972015", "GSM972016", "GSM972017", "GSM972018", "GSM972019", "GSM972020", "GSM972021", "GSM972022", "GSM972023", "GSM972024", "GSM972025", "GSM972026", "GSM972027", "GSM972028", "GSM972029", "GSM972030", "GSM972031", "GSM972032", "GSM972033", "GSM972034", "GSM972035", "GSM972036", "GSM972037", "GSM972038", "GSM972039", "GSM972040", "GSM972041", "GSM972042", "GSM972043", "GSM972044", "GSM972045", "GSM972046", "GSM972047", "GSM972048", "GSM972049", "GSM972050", "GSM972051", "GSM972052", "GSM972053", "GSM972054", "GSM972055", "GSM972056", "GSM972057", "GSM972058", "GSM972059", "GSM972060", "GSM972061", "GSM972062", "GSM972063", "GSM972064", "GSM972065", "GSM972066", "GSM972067", "GSM972068", "GSM972069", "GSM972070", "GSM972071", "GSM972072", "GSM972073", "GSM972074", "GSM972075", "GSM972076", "GSM972077", "GSM972078", "GSM972079", "GSM972080", "GSM972081", "GSM972082", "GSM972083", "GSM972084", "GSM972085", "GSM972086", "GSM972087", "GSM972088", "GSM972089", "GSM972090", "GSM972091", "GSM972092", "GSM972093", "GSM972094", "GSM972095", "GSM972096", "GSM972097", "GSM972098", "GSM972099", "GSM972100", "GSM972101", "GSM972102", "GSM972103", "GSM972104", "GSM972105", "GSM972106", "GSM972107", "GSM972108", "GSM972109", "GSM972110", "GSM972111", "GSM972112", "GSM972113", "GSM972114", "GSM972115", "GSM972116", "GSM972117", "GSM972118", "GSM972119", "GSM972120", "GSM972121", "GSM972122", "GSM972123", "GSM972124", "GSM972125", "GSM972126", "GSM972127", "GSM972128", "GSM972129", "GSM972130", "GSM972131", "GSM972132", "GSM972133", "GSM972134", "GSM972135", "GSM972136", "GSM972137", "GSM972138", "GSM972139", "GSM972140", "GSM972141", "GSM972142", "GSM972143", "GSM972144", "GSM972145", "GSM972146", "GSM972147", "GSM972148", "GSM972149", "GSM972150", "GSM972151", "GSM972152", "GSM972153", "GSM972154", "GSM972155", "GSM972156", "GSM972157", "GSM972158", "GSM972159", "GSM972160", "GSM972161", "GSM972162", "GSM972163", "GSM972164", "GSM972165", "GSM972166", "GSM972167", "GSM972168", "GSM972169", "GSM972170", "GSM972171", "GSM972172", "GSM972173", "GSM972174", "GSM972175", "GSM972176", "GSM972177", "GSM972178", "GSM972179", "GSM972180", "GSM972181", "GSM972182", "GSM972183", "GSM972184", "GSM972185", "GSM972186", "GSM972187", "GSM972188", "GSM972189", "GSM972190", "GSM972191", "GSM972192", "GSM972193", "GSM972194", "GSM972195", "GSM972196", "GSM972197", "GSM972198", "GSM972199", "GSM972200", "GSM972201", "GSM972202", "GSM972203", "GSM972204", "GSM972205", "GSM972206", "GSM972207", "GSM972208", "GSM972209", "GSM972210", "GSM972211", "GSM972212", "GSM972213", "GSM972214", "GSM972215", "GSM972216", "GSM972217", "GSM972218", "GSM972219", "GSM972220", "GSM972221", "GSM972222", "GSM972223", "GSM972224", "GSM972225", "GSM972226", "GSM972227", "GSM972228", "GSM972229", "GSM972230", "GSM972231", "GSM972232", "GSM972233", "GSM972234", "GSM972235", "GSM972236", "GSM972237", "GSM972238", "GSM972239", "GSM972240", "GSM972241", "GSM972242", "GSM972243", "GSM972244", "GSM972245", "GSM972246", "GSM972247", "GSM972248", "GSM972249", "GSM972250", "GSM972251", "GSM972252", "GSM972253", "GSM972254", "GSM972255", "GSM972256", "GSM972257", "GSM972258", "GSM972259", "GSM972260", "GSM972261", "GSM972262", "GSM972263", "GSM972264", "GSM972265", "GSM972266", "GSM972267", "GSM972268", "GSM972269", "GSM972270", "GSM972271", "GSM972272", "GSM972273", "GSM972274", "GSM972275", "GSM972276", "GSM972277", "GSM972278", "GSM972279", "GSM972280", "GSM972281", "GSM972282", "GSM972283", "GSM972284", "GSM972285", "GSM972286", "GSM972287", "GSM972288", "GSM972289", "GSM972290", "GSM972291", "GSM972292", "GSM972293", "GSM972294", "GSM972295", "GSM972296", "GSM972297", "GSM972298", "GSM972299", "GSM972300", "GSM972301", "GSM972302", "GSM972303", "GSM972304", "GSM972305", "GSM972306", "GSM972307", "GSM972308", "GSM972309", "GSM972310", "GSM972311", "GSM972312", "GSM972313", "GSM972314", "GSM972315", "GSM972316", "GSM972317", "GSM972318", "GSM972319", "GSM972320", "GSM972321", "GSM972322", "GSM972323", "GSM972324", "GSM972325", "GSM972326", "GSM972327", "GSM972328", "GSM972329", "GSM972330", "GSM972331", "GSM972332", "GSM972333", "GSM972334", "GSM972335", "GSM972336", "GSM972337", "GSM972338", "GSM972339", "GSM972340", "GSM972341", "GSM972342", "GSM972343", "GSM972344", "GSM972345", "GSM972346", "GSM972347", "GSM972348", "GSM972349", "GSM972350", "GSM972351", "GSM972352", "GSM972353", "GSM972354", "GSM972355", "GSM972356", "GSM972357", "GSM972358", "GSM972359", "GSM972360", "GSM972361", "GSM972362", "GSM972363", "GSM972364", "GSM972365", "GSM972366", "GSM972367", "GSM972368", "GSM972369", "GSM972370", "GSM972371", "GSM972372", "GSM972373", "GSM972374", "GSM972375", "GSM972376", "GSM972377", "GSM972378", "GSM972379", "GSM972380", "GSM972381", "GSM972382", "GSM972383", "GSM972384", "GSM972385", "GSM972386", "GSM972387", "GSM972388", "GSM972389", "GSM972390", "GSM972391", "GSM972392", "GSM972393", "GSM972394", "GSM972395", "GSM972396", "GSM972397", "GSM972398", "GSM972399", "GSM972400", "GSM972401", "GSM972402", "GSM972403", "GSM972404", "GSM972405", "GSM972406", "GSM972407", "GSM972408", "GSM972409", "GSM972410", "GSM972411", "GSM972412", "GSM972413", "GSM972414", "GSM972415", "GSM972416", "GSM972417", "GSM972418", "GSM972419", "GSM972420", "GSM972421", "GSM972422", "GSM972423", "GSM972424", "GSM972425", "GSM972426", "GSM972427", "GSM972428", "GSM972429", "GSM972430", "GSM972431", "GSM972432", "GSM972433", "GSM972434", "GSM972435", "GSM972436", "GSM972437", "GSM972438", "GSM972439", "GSM972440", "GSM972441", "GSM972442", "GSM972443", "GSM972444", "GSM972445", "GSM972446", "GSM972447", "GSM972448", "GSM972449", "GSM972450", "GSM972451", "GSM972452", "GSM972453", "GSM972454", "GSM972455", "GSM972456", "GSM972457", "GSM972458", "GSM972459", "GSM972460", "GSM972461", "GSM972462", "GSM972463", "GSM972464", "GSM972465", "GSM972466", "GSM972467", "GSM972468", "GSM972469", "GSM972470", "GSM972471", "GSM972472", "GSM972473", "GSM972474", "GSM972475", "GSM972476", "GSM972477", "GSM972478", "GSM972479", "GSM972480", "GSM972481", "GSM972482", "GSM972483", "GSM972484", "GSM972485", "GSM972486", "GSM972487", "GSM972488", "GSM972489", "GSM972490", "GSM972491", "GSM972492", "GSM972493", "GSM972494", "GSM972495", "GSM972496", "GSM972497", "GSM972498", "GSM972499", "GSM972500", "GSM972501", "GSM972502", "GSM972503", "GSM972504", "GSM972505", "GSM972506", "GSM972507", "GSM972508", "GSM972509", "GSM972510", "GSM972511", "GSM972512", "GSM972513", "GSM972514", "GSM972515", "GSM972516", "GSM972517", "GSM972518", "GSM972519", "GSM972520", "GSM972521", "GSM972522"], "sample_count": 585, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Gene expression Classification of Colon Cancer defines six molecular subtypes with distinct clinical, molecular and survival characteristics [Expression]", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:29915691:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:e063dffe84c46123eaf3ce08fd75a018dbdb53c5f8ff2ec20c42561a21d819ce", "bytes": 1051, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#table-1", "version": null, "note": "Clinicopathologic features of 240 TCGA COAD patients.", "structure": {"pmcid": "PMC6004299", "section_index": 11, "section_title": "Phase II", "row_count": 21, "column_count": 4}, "table": {"label": "Table 1", "caption": "Clinicopathologic features of 240 TCGA COAD patients.", "rows": [["Characteristic", "Training set (N = 119)", "Testing set (N = 121)", "pvalue"], ["", "No. of patients (%)", "No. of patients (%)", ""], ["Age (mean ± SD)", "66.4 ± 13.0", "63.2 ± 13.8", "0.069a"], ["Gender", "", "", ""], ["Male", "60 (50.4%)", "54 (44.6%)", "0.438b"], ["Female", "59 (49.6%)", "67 (55.4%)"], ["Stage", "", "", ""], ["I", "20 (16.8%)", "20 (16.5%)", "0.998c"], ["II", "47 (39.5%)", "48 (39.7%)"], ["III and IV", "52 (43.7%)", "53 (43.8%)"], ["Primary tumor", "", "", ""], ["T1 and T2", "20 (16.8%)", "23 (19.0%)", "0.737b"], ["T3 and T4", "99 (83.2%)", "98 (81.0%)"], ["Microsatellite status", "", "", ""], ["MSI-L", "23 (19.3%)", "23 (19.0%)", "0.995c"], ["MSI-H", "20 (16.8%)", "20 (16.5%)"], ["MSS", "76 (63.9%)", "78 (64.4%)"], ["Lymphatic_invasion", "", "", ""], ["No", "77 (64.7%)", "77 (63.6%)", "0.999b"], ["Yes", "33 (27.7%)", "34 (28.1%)"], ["Unknown", "9 (7.6%)", "10 (8.3%)", "Excluded"]], "row_count": 21, "column_count": 4, "numeric_cells": 36, "header_rows": 2, "locator": "section[11]/table-wrap[1]#table-1"}}, {"id": "asset:table:pmid:29915691:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:dd8832744bcb96f33758e1b250d1d2622700ddebd99de81684746c3a6155ad50", "bytes": 1716, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[1]#table-2", "version": null, "note": "Statistics of the ROC analysis.", "structure": {"pmcid": "PMC6004299", "section_index": 14, "section_title": "Development of signature prototype", "row_count": 27, "column_count": 6}, "table": {"label": "Table 2", "caption": "Statistics of the ROC analysis.", "rows": [["Signature", "AUC", "SE", "Progressivep", "Progressive 95% CIs"], ["", "", "", "", "Lower bound", "Upper bound"], ["16-gene", "0.7517", "0.0531", "0.0000", "0.6476", "0.8558"], ["36-gene", "0.7600", "0.0529", "0.0000", "0.6562", "0.8637"], ["40-gene", "0.7653", "0.0520", "0.0000", "0.6634", "0.8672"], ["42-gene", "0.7609", "0.0525", "0.0000", "0.6581", "0.8638"], ["44-gene", "0.7604", "0.0525", "0.0000", "0.6576", "0.8633"], ["46-gene", "0.7614", "0.0524", "0.0000", "0.6588", "0.8641"], ["48-gene", "0.7575", "0.0528", "0.0000", "0.6540", "0.8610"], ["50-gene", "0.7541", "0.0530", "0.0000", "0.6503", "0.8580"], ["56-gene", "0.7493", "0.0532", "0.0000", "0.6450", "0.8536"], ["58-gene", "0.7488", "0.0533", "0.0000", "0.6444", "0.8532"], ["60-gene", "0.7483", "0.0532", "0.0000", "0.6439", "0.8527"], ["62-gene", "0.7478", "0.0533", "0.0000", "0.6433", "0.8524"], ["64-gene", "0.7468", "0.0534", "0.0001", "0.6421", "0.8515"], ["66-gene", "0.7459", "0.0535", "0.0001", "0.6409", "0.8508"], ["68-gene", "0.7449", "0.0534", "0.0001", "0.6402", "0.8496"], ["70-gene", "0.7459", "0.0534", "0.0001", "0.6412", "0.8505"], ["72-gene", "0.7468", "0.0534", "0.0001", "0.6422", "0.8514"], ["74-gene", "0.7444", "0.0535", "0.0001", "0.6395", "0.8493"], ["76-gene", "0.7444", "0.0535", "0.0001", "0.6396", "0.8492"], ["78-gene", "0.7430", "0.0537", "0.0001", "0.6377", "0.8482"], ["80-gene", "0.7410", "0.0539", "0.0001", "0.6354", "0.8467"], ["82-gene", "0.7420", "0.0538", "0.0001", "0.6365", "0.8474"], ["84-gene", "0.7410", "0.0539", "0.0001", "0.6353", "0.8467"], ["86-gene", "0.7410", "0.0539", "0.0001", "0.6354", "0.8466"], ["118-gene", "0.7347", "0.0542", "0.0001", "0.6284", "0.8410"]], "row_count": 27, "column_count": 6, "numeric_cells": 151, "header_rows": 2, "locator": "section[14]/table-wrap[1]#table-2"}}, {"id": "asset:table:pmid:29915691:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:9920b5557cb701909e226ace8b5026d5422f57127251d9fadf79c2f5e91d5869", "bytes": 550, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[1]#table-3", "version": null, "note": "Distribution of advanced stage patients between high- and low-score group.Fisher’s exact test was used for statistical analysis.", "structure": {"pmcid": "PMC6004299", "section_index": 16, "section_title": "Prognostic values of the 12-gene signature in other COAD datasets", "row_count": 5, "column_count": 5}, "table": {"label": "Table 3", "caption": "Distribution of advanced stage patients between high- and low-score group.Fisher’s exact test was used for statistical analysis.", "rows": [["Dataset", "Group", "Stage I & II", "Stage III & IV", "pvalue"], ["GSE17538", "High score group", "19 (20%)", "78 (80%)", "0.0003"], ["Low score group", "43 (44%)", "54 (56%)"], ["TCGA", "High score group", "53 (49%)", "55 (51%)", "0.0277"], ["Low score group", "69 (64%)", "38 (36%)"]], "row_count": 5, "column_count": 5, "numeric_cells": 11, "header_rows": 1, "locator": "section[16]/table-wrap[1]#table-3"}}], "gaps": ["asset:data:geo:GSE39582 not downloaded", "asset:data:geo:GSE39582 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "KM"}}, {"id": "method-3", "family": "contingency_analysis", "specific": "fisher_exact", "label": "Categorical (contingency table) analysis", "dsl_operations": ["contingency_table", "chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.7, "band": "medium", "quote": "Fisher's exact"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["logrank_test"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: log_rank_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE39582", "GSE17538 (GSE17536 and GSE17537)"], "resolved_accessions": ["GSE39582"], "statements": ["The following information was supplied regarding data availability:\nDetailed clinical information of TCGA patients enrolled in phase I and phase II training stage were listed in Tables S1 and S2, respectively.\nThe detailed clinical information of TCGA patients enrolled in phase I and phase II training stages are listed in Tables S1–S3."], "basis": "The paper names GSE39582 in Gene Expression Omnibus (GEO) database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["logrank_test"], "assets": ["source:pmid:29915691", "data:geo:GSE39582", "asset:table:pmid:29915691:1", "asset:table:pmid:29915691:2", "asset:table:pmid:29915691:3"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE39582"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:34:57Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 117338, "completion_tokens": 4584, "cached_tokens": 2104}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:29915691", "type": "paper", "label": "pmid:29915691"}, {"id": "source:pmid:29915691", "type": "manuscript", "label": "PMID 29915691 full text"}, {"id": "data:geo:GSE39582", "type": "dataset", "label": "GEO GSE39582"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:29915691", "type": "paper", "label": "pmid:29915691"}, {"id": "source:pmid:29915691", "type": "manuscript", "label": "PMID 29915691 full text"}, {"id": "data:geo:GSE39582", "type": "dataset", "label": "GEO GSE39582"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-29915691", "type": "extraction", "used": ["source:pmid:29915691"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE39582", "type": "accession_resolution", "used": ["data:geo:GSE39582"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:29915691", "parent_hash": "sha256:83401a0c7bbfbb5cc1403c78f07d24ad1b1e17385a10ff26cffaaeae4e53ca51", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:GSE39582 licence not read", "asset:data:geo:GSE39582 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["denocarcinoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome At", "inoma (COAD) prognosis by using COAD RNA-seq transcriptome data from The Cancer Genome Atlas (TCGA). Th"], "order_basis": "paper_text_order:460", "id": "assay:1"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["lidated with two independent gene expression microarray datasets: GSE39582 includes 566 COAD cases f"], "order_basis": "paper_text_order:627", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["logrank_test"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Survival comparisons between high and low risk groups were conducted by Kaplan–Meier plotting. Log Rank p value <0.05 was considered as significantly different."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}